VLON
Price:
$0.4
Market Cap:
$0
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.[Read more]
Industry
Biotechnology
IPO Date
2021-02-10
Stock Exchange
NASDAQ
Ticker
VLON
According to Vallon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.11. This represents a change of 40.63% compared to the average of 2.21 of the last 4 quarters.
The mean historical Current Ratio of Vallon Pharmaceuticals, Inc. over the last ten years is 2.20. The current 3.11 Current Ratio has changed 14.04% with respect to the historical average. Over the past ten years (40 quarters), VLON's Current Ratio was at its highest in in the September 2021 quarter at 7.55. The Current Ratio was at its lowest in in the September 2019 quarter at 0.
Average
2.20
Median
1.80
Minimum
0.30
Maximum
4.86
Discovering the peaks and valleys of Vallon Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 997.56%
Maximum Annual Current Ratio = 4.86
Minimum Annual Increase = -93.76%
Minimum Annual Current Ratio = 0.30
Year | Current Ratio | Change |
---|---|---|
2023 | 1.09 | -52.58% |
2022 | 2.29 | -31.00% |
2021 | 3.32 | 997.56% |
2020 | 0.30 | -93.76% |
2019 | 4.86 | 270.39% |
The current Current Ratio of Vallon Pharmaceuticals, Inc. (VLON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.24
5-year avg
2.37
10-year avg
2.20
Vallon Pharmaceuticals, Inc.’s Current Ratio is less than Ikena Oncology, Inc. (18.22), less than Foghorn Therapeutics Inc. (5.69), less than Werewolf Therapeutics, Inc. (12.13), greater than Clene Inc. (0.99), less than Immunome, Inc. (7.12), less than Zura Bio Limited (12.57), less than Phio Pharmaceuticals Corp. (3.47), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than 180 Life Sciences Corp. (0.58), less than Cardio Diagnostics Holdings, Inc. (5.69), less than Palisade Bio, Inc. (4.31), less than Quoin Pharmaceuticals, Ltd. (3.35), greater than Revelation Biosciences, Inc. (1.10), less than Virax Biolabs Group Limited (25.94), less than Unicycive Therapeutics, Inc. (3.37), greater than ContraFect Corporation (0.53), greater than Allarity Therapeutics, Inc. (2.01), greater than CNS Pharmaceuticals, Inc. (0.31), greater than Windtree Therapeutics, Inc. (0.23), greater than Panbela Therapeutics, Inc. (0.05),
Company | Current Ratio | Market cap |
---|---|---|
18.22 | $81.56M | |
5.69 | $416.63M | |
12.13 | $88.28M | |
0.99 | $38.37M | |
7.12 | $813.14M | |
12.57 | $230.86M | |
3.47 | $2.25M | |
1.65 | $4.53M | |
0.58 | $1.89M | |
5.69 | $6.94M | |
4.31 | $4.25M | |
3.35 | $3.06M | |
1.10 | $1.43M | |
25.94 | $15.24M | |
3.37 | $33.41M | |
0.53 | $1.72M | |
2.01 | $7.01M | |
0.31 | $4.60M | |
0.23 | $1.66M | |
0.05 | $1.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vallon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vallon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Vallon Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Vallon Pharmaceuticals, Inc. (VLON)?
What is the highest Current Ratio for Vallon Pharmaceuticals, Inc. (VLON)?
What is the 3-year average Current Ratio for Vallon Pharmaceuticals, Inc. (VLON)?
What is the 5-year average Current Ratio for Vallon Pharmaceuticals, Inc. (VLON)?
How does the current Current Ratio for Vallon Pharmaceuticals, Inc. (VLON) compare to its historical average?